B

BTAI

Bioxcel Therapeutics Inc

1.120

+0.080+7.69%
Opening10:50 04/30 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Total Assets

44.92M

38.34M

73.70M

205.85M

239.44M

Total Current Assets

44.69M

37.39M

72.14M

202.87M

236.81M

Total Non Current Assets

231.00K

944.00K

1.56M

2.98M

2.63M

Total Liabilities

140.38M

131.44M

130.21M

129.08M

17.77M

Total Current Liabilities

53.93M

22.23M

27.27M

32.90M

16.67M

Total Non Current Liabilities

86.45M

109.21M

102.94M

96.18M

1.10M

Total Equity

-95.46M

-93.10M

-56.51M

76.78M

221.67M

Total Stockholders Equity

-95.46M

-93.10M

-56.51M

76.78M

221.67M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

44.92M

38.34M

73.70M

205.85M

239.44M

Total Common Shares Outstanding

22.33M

3.10M

1.87M

1.76M

1.75M

Total Preferred Shares Outstanding

--

--

--

--

--